Skip to main content
SpringerLink
Log in

Uveitis bei Kindern und Jugendlichen mit juveniler idiopathischer Arthritis

  • Chapter
  • First Online:
Pädiatrische Rheumatologie

Part of the book series: Springer Reference Medizin ((SRM))

Zusammenfassung

Etwa jedes 10. Kind mit juveniler idiopathischer Arthritis weist eine Augenbeteiligung in Form einer oftmals bilateralen anterioren Uveitis auf. Typisch ist ein chronischer asymptomatischer Verlauf mit hoher Komplikationsrate und dem Risiko einer bleibenden Visusminderung. Das Uveitis-Screening sollte unmittelbar nach Erstdiagnose der Gelenkentzündung erfolgen. Der individuelle Verlauf von Uveitis und Arthritis muss in die interdisziplinäre Therapieentscheidung einfließen. Unter frühzeitiger Verwendung von disease-modifying antirheumatic drugs (DMARDs) können die Uveitisinzidenz reduziert und die Langzeitprognose verbessert werden.

Die Affiliation von Christoph Tappeiner wurde falsch eingebunden und wurde korrigiert.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 219.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 229.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Angeles-Han ST, Lo MS, Henderson LA et al (2019a) Childhood arthritis and rheumatology research alliance consensus treatment plans for juvenile idiopathic arthritis-associated and idiopathic chronic anterior uveitis. Arthritis Care Res 71:482–491

    Article  Google Scholar 

  • Angeles-Han ST, Ringold S, Beukelman T et al (2019b) 2019 American College of Rheumatology/Arthritis Foundation guideline for screening, monitoring, and treatment of juvenile idiopathic arthritis-associated uveitis. Arthritis Rheumatol 71:864–877

    Article  PubMed  PubMed Central  Google Scholar 

  • AWMF Leitlinie Register Nr. 045/012 (2018) Diagnostik und antientzündliche Therapie der Uveitis bei juveniler idiopathischer Arthritis

    Google Scholar 

  • Bauermann P, Heiligenhaus A, Heinz C (2019) Effect of janus kinase inhibitor treatment on anterior uveitis and associated macular edema in an adult patient with juvenile idiopathic arthritis. Ocul Immunol Inflamm 27:1232–1234

    Article  CAS  PubMed  Google Scholar 

  • Beukelman T, Ringold S, Davis TE et al (2012) Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry. J Rheumatol 39:1867–1874

    Article  PubMed  PubMed Central  Google Scholar 

  • Boer J de, Steijaert A, van den Bor R et al (2015) Development of macular edema and impact on visual acuity in uveitis associated with juvenile idiopathic arthritis. Ocul Immunol Inflamm 23:67–73

    Google Scholar 

  • Böhm MR, Tappeiner C, Breitbach MA et al (2017) Ocular hypotony in patients with juvenile idiopathic arthritis-associated uveitis. Am J Ophthalmol 173:45–55

    Article  PubMed  Google Scholar 

  • Busch M, Wefelmeyer KL, Walscheid K et al (2019) Identification of ocular autoantigens associated with juvenile idiopathic arthritis-associated uveitis. Front Immunol 10:1793. https://doi.org/10.3389/Fimmun.2019.01793. eCollection

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Calvo-Rio V, Santos-Gomez M, Calvo I et al (2016) Anti-IL-6R tocilizumab for severe juvenile idiopathic arthritis-associated uveitis refractory to anti-TNF therapy. A multicenter study of 25 patients. Arthritis Rheumatol 69:668–675

    Article  CAS  Google Scholar 

  • Carvounis PE, Herman DC, Cha S et al (2006) Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefes Arch Clin Exp Ophthalmol 244:281–290

    Article  PubMed  Google Scholar 

  • Chia A, Lee V, Graham EM et al (2003) Factors related to severe uveitis at diagnosis in children with juvenile idiopathic arthritis in a screening program. Am J Ophthalmol 135:757–762

    Article  PubMed  Google Scholar 

  • Cordero-Coma M, Calvo-Rio V, Adan A et al (2014) Golimumab as rescue therapy for refractory immune-mediated uveitis: a three-center experience. Mediat Inflamm 2014:717598

    Article  CAS  Google Scholar 

  • Dana MR, Merayo-Lloves J et al (1997) Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis. Ophthalmology 104:236–244

    Article  CAS  PubMed  Google Scholar 

  • Diaz-Llopis M, Salom D, Garcia-de-Vicuna C et al (2012) Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients. Ophthalmology 119:1575–1581

    Article  PubMed  Google Scholar 

  • Edelsten C, Lee V, Bentley CR et al (2002) An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood. Br J Ophthalmol 86:51–56

    Article  PubMed  PubMed Central  Google Scholar 

  • Edelsten C, Reddy MA, Stanford MR, Graham EM (2003) Visual loss associated with pediatric uveitis in english primary and referral centers. Am J Ophthalmol 135:676–680

    Article  PubMed  Google Scholar 

  • Foeldvari I, Wierk A (2005) Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis. J Rheumatol 32:362–365

    CAS  PubMed  Google Scholar 

  • Foeldvari I, Nielsen S, Kummerle-Deschner J et al (2007) Tumor necrosis factor-alpha blocker in treatment of juvenile idiopathic arthritis-associated uveitis refractory to second-line agents: results of a multinational survey. J Rheumatol 34:1146–1150

    CAS  PubMed  Google Scholar 

  • Foster CS, Barrett F (1993) Cataract development and cataract surgery in patients with juvenile rheumatoid arthritis-associated iridocyclitis. Ophthalmology 100:809–817

    Article  CAS  PubMed  Google Scholar 

  • Gerloni V, Cimaz R, Gattinara M et al (2001) Efficacy and safety profile of cyclosporin A in the treatment of juvenile chronic (idiopathic) arthritis. Results of a 10-year prospective study. Rheumatology (Oxford) 40:907–913

    Article  CAS  Google Scholar 

  • Goebel J, Rosel M, Heinz C et al (2011) Azathioprine as a treatment option for uveitis in patients with juvenile idiopathic arthritis. Br J Ophthalmol 95:209–213

    Article  CAS  PubMed  Google Scholar 

  • Grajewski R, Zurek-Imhoff B, Rösel M et al (2012) Favourable outcome after cataract surgery with IOL implantation in uveitis associated with juvenile idiopathic arthritis. Acta Ophthalmol 90:657–662

    Article  PubMed  Google Scholar 

  • Haasnoot AJ, van Tent-Hoeve M, Wulffraat NM et al (2015) Erythrocyte sedimentation rate as baseline predictor for the development of uveitis in children with juvenile idiopathic arthritis. Am J Ophthalmol 159:372–377

    Article  PubMed  Google Scholar 

  • Haasnoot AJW, Schilham MW, Kamphuis S et al (2018) Identification of an amino acid motif in HLA-DRß1 that distiguishes uveitis in patients with juvenile idiopathic arthritis. Arthritis Rheumatol 70:1155–1165

    Article  CAS  PubMed  Google Scholar 

  • Haasnoot AJW, Kuiper JJW, de Boer JH (2019) Predicting uveitis in juvenile idiopathic arthritis: from biomarkers to clinical practice. Expert Rev Clin Immunol 15:657–666

    Article  CAS  PubMed  Google Scholar 

  • Heiligenhaus A, Mingels A, Heinz C et al (2007a) Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication. Eur J Ophthalmol 17:743–748

    Article  CAS  PubMed  Google Scholar 

  • Heiligenhaus A, Niewerth M, Ganser G et al (2007b) Prevalence and complications of uveitis in juvenile idiopathic arthritis in a population-based nation-wide study in Germany: suggested modification of the current screening guidelines. Rheumatology 46:1015–1019

    Article  CAS  PubMed  Google Scholar 

  • Heiligenhaus A, Miserocchi E, Heinz C et al (2011) Treatment of severe uveitis associated with juvenile idiopathic arthritis with anti-CD20 monoclonal antibody (rituximab). Rheumatology 50:1390–1394

    Article  CAS  PubMed  Google Scholar 

  • Heiligenhaus A, Minden K, Tappeiner C et al (2019) Update of the evidence based, interdisciplinary guideline for anti-inflammatory treatment of uveitis associated with juvenile idiopathic arthritis. Semin Arthritis Rheum 49:43–55

    Article  CAS  PubMed  Google Scholar 

  • Heiligenhaus A, Klotsche J, Niewerth M et al (2020) Similarities in clinical course and outcome between juvenile idiopathic arthritis (JIA)-associated and ANA-positive idiopathic anterior uveitis: data from a population-based nationwide study in Germany. Arthritis Res Ther, in Revision 22(1):81. https://doi.org/10.1186/s13075-020-02166-3

  • Heinz C, Koch JM, Heiligenhaus A (2006) Transcleral diode laser cyclophotocoagulation as primary surgical treatment for secondary glaucoma in juvenile idiopathic arthritis: high failure rate after short term follow up. Br J Ophthalmol 90:737–740

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Heinz C, Pleyer U, Ruokonnen P, Heiligenhaus A (2008) Secondary glaucoma in childhood uveitis. Ophthalmologe 105:438–444

    Article  CAS  PubMed  Google Scholar 

  • Heinz C, Schumacher C, Roesel M, Heiligenhaus A (2012) Elevated intraocular pressure in uveitis accociated with juvenile idiopathic arthritis-associated uveitis, often detected after acchieving inactivity. Br J Ophthalmol 96:140–141

    Article  PubMed  Google Scholar 

  • Horton S, Jones AP, Guly CM et al (2019) Adalimumab in juvenile idiopathic arthritis-associated uveitis: 5-year follow-up of the Bristol participants of the SYCAMORE trial. Am J Ophthalmol 207:170–174

    Article  CAS  PubMed  Google Scholar 

  • Jabs DA, Nussenblatt RB, Rosenbaum JT (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140:509–516

    Article  PubMed  Google Scholar 

  • Kakkassery V, Mergler S, Pleyer U (2010) Anti-TNF-alpha treatment: a possible promoter in endogenous uveitis? Observational report on six patients: occurrence of uveitis following etanercept treatment. Curr Eye Res 35:751–756

    Article  CAS  PubMed  Google Scholar 

  • Kalinina Avuso V, ten Cate HA, van der Does P et al (2010) Male gender as a risk factor for complications in uveitis associated with juvenile idiopathic arthritis. Am J Ophthalmol 149:994–999

    Article  Google Scholar 

  • Kalinina Ayuso V, van de Winkel EL, Rothova A, de Boer JH (2011) Relapse rate of uveitis post-methotrexate treatment in juvenile idiopathic arthritis. Am J Ophthalmol 151:217–222

    Article  PubMed  Google Scholar 

  • Kalinina Ayuso V, van Dijk MR, de Boer JH (2015) Infiltration of plasma cells in the iris of children with ANA-positive anterior uveitis. Invest Ophthalmol Vis Sci 56:6770–6778

    Article  PubMed  Google Scholar 

  • Kanski JJ (1988) Uveitis in juvenile chronic arthritis: incidence, clinical features and prognosis. Eye 2:641–645

    Article  PubMed  Google Scholar 

  • Kanski JJ (1990) Uveitis in juvenile chronic arthritis. Clin Exp Rheumatol 8:499–503

    CAS  PubMed  Google Scholar 

  • Kanski JJ (1992) Lensectomy for complicated cataract in juvenile chronic iridocyclitis. Br J Ophthalmol 76:72–75

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kenawy N, Clearny G, Mewar D et al (2011) Abatacept: a potential therapy in refractory cases of juvenile idiopathic arthritis-associated uveitis. Graefes Arch Clin Exp Ophthalmol 249:297–300

    Article  PubMed  Google Scholar 

  • Kotaniemi K, Penttila H (2006) Intraocular lens implantation in patients with juvenile idiopathic arthritis-associated uveitis. Ophthalmic Res 38:318–323

    Article  PubMed  Google Scholar 

  • Kotaniemi K, Kaipiainen-Seppanen O, Savolainen A, Karma A (1999) A population-based study on uveitis in juvenile rheumatoid arthritis. Clin Exp Rheumatol 17:119–122

    CAS  PubMed  Google Scholar 

  • Kotaniemi K, Kautiainen H, Karma A, Aho K (2001) Occurrence of uveitis in recently diagnosed juvenile chronic arthritis: a prospective study. Ophthalmology 108:2071–2075

    Article  CAS  PubMed  Google Scholar 

  • Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, Leirisalo-Repo M (2005) Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis 64:871–874

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kothari S, Foster CS, Pistilli M et al (2015) The risk of intraocular pressure elevation in pediatric non-infectious uveitis. Ophthalmology 122:1987–2001

    Article  PubMed  Google Scholar 

  • Lerman MA, Lewen MD, Kempen JH, Mills MD (2015) Uveitis reactivation in children treated with tumor necrosis factor alpha inhibitors. Am J Ophthalmol 160:193–200

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Miserocchi E, Modorati G, Pontikaki I et al (2014) Long-term treatment with golimumab for severe uveitis. Ocul Immunol Inflamm 22:90–95

    Article  CAS  PubMed  Google Scholar 

  • Miserocchi E, Modorati G, Berchicci L et al (2016) Long-term treatment with rituximab in severe juvenile idiopathic arthritis-associated uveitis. Br J Ophthalmol 100:782–786

    Article  PubMed  Google Scholar 

  • Miserocchi E, Giuffre C, Cornalba M et al (2020) JAK inhibitors in refractory juvenile idiopathic arthritis-associated uveitis. Clin Rheumatol. https://doi.org/10.1007/s10067-019-04875-w. [Epub ahead of print]

  • Paivonsalo-Hietanen T, Tuominen J, Saari KM (2000) Uveitis in children: Population-based study in Finland. Acta Ophthalmol Scand 78:84–88

    Article  CAS  PubMed  Google Scholar 

  • Parikh JG, Tawansy KA, Rao NA (2008) Immunhistochemical study of chronic nongranulomatous anterior uveitis in juvenile idiopathic arthritis. Ophthalmology 115:1833–1836

    Article  PubMed  Google Scholar 

  • Rabinovich CE (2011) Treatment of juvenile idiopathic arthritis-associated uveitis: challenges and update. Curr Opin Rheumatol 23:432–436

    Article  CAS  PubMed  Google Scholar 

  • Ramanan AV, Dick AD, Jones AP et al (2017) Adalimumab plus methotrexate for uveitis in juvenile idiopathic arthritis. N Engl J Med 376:1637–1646

    Article  CAS  PubMed  Google Scholar 

  • Saboo US, Metzinger JL, Radwan A et al (2013) Risk factors associated with the relapse of uveitis in patients with juvenile idiopathic arthritis: a preliminary report. J AAPOS 17:460–464

    Article  PubMed  Google Scholar 

  • Saurenmann RK, Levin AV, Feldman BM et al (2006a) Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents. J Pediatr 149:833–836

    Article  CAS  PubMed  Google Scholar 

  • Saurenmann RK, Levin AV, Rose JB et al (2006b) Tumour necrosis factor alpha inhibitors in the treatment of childhood uveitis. Rheumatology (Oxford) 45:982–989

    Article  CAS  Google Scholar 

  • Saurenmann RK, Levin AV, Feldman BM et al (2010) Risk factors for development of uveitis differ between girls and boys with juvenile idiopathic arthritis. Arthritis Rheum 62:1824–1828

    Article  CAS  PubMed  Google Scholar 

  • Sengler C, Zink J, Klotsche J et al (2018) Vitamin D deficiency is associated with higher disease activity and the risk for uveitis in juvenile idiopathic arthritis – data from a German inception cohort. Arthritis Res Ther 20(1):276. https://doi.org/10.1186/s13075-018-1765-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Shakoor A, Esterberg E, Acharya NR (2014) Recurrence of uveitis after discontinuation of infliximab. Ocul Immunol Inflamm 22:96–101

    Article  CAS  PubMed  Google Scholar 

  • Shechter R, London A, Schwartz M (2013) Orchestrated leukocyte recruitment to immune-privileged sites: absolute barriers versus educational gates. Nat Rev Immunol 13:206–218

    Article  CAS  PubMed  Google Scholar 

  • Simonini G, Taddio A, Cattalini M et al (2011) Prevention of flare recurrences in childhood-refractory chronic uveitis: an open-label comparative study of adalimumab versus infliximab. Arthritis Care Res 63:612–618

    Article  CAS  Google Scholar 

  • Simonini G, Taddio A, Cattalini M et al (2013) Superior efficacy of adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: adalimumab as starting anti-TNF-a therapy in childhood chronic uveitis. Pediatr Rheumatol 11:16

    Article  Google Scholar 

  • Simonini G, Druce K, Cimaz R et al (2014) Current evidence of anti-tumor necrosis factor a treatment efficacy in childhood chronic uveitis: a systemic review and meta-analysis approach of individual drugs. Arthritis Care Res 66:1073–1084

    Article  CAS  Google Scholar 

  • Simonini G, Bracaglia C, Cattalini M et al (2017) Predictors of relapse after discontinuing systemic treatment in childhood autoimmune chronic uveitis. J Rheumatol 44:822–826

    Article  CAS  PubMed  Google Scholar 

  • Tappeiner C, Roesel M, Heinz C et al (2009) Limited value of cyclosporine A for the treatment of patients with uveitis associated with juvenile idiopathic arthritis. Eye 23:1192–1198

    Article  CAS  PubMed  Google Scholar 

  • Tappeiner C, Heinz C, Rösel M, Heiligenhaus A (2011) Elevated laser flare values correlate with complicated course of anterior uveitis in patients with juvenile idiopathic arthritis. Acta Ophthalmol 89:e521–e521

    Article  PubMed  Google Scholar 

  • Tappeiner C, Miserocchi E, Bodaghi B et al (2015a) Abatacept in the treatment of severe, longstanding and refractory uveitis associated with juvenile idiopathic arthritis. J Rheumatol 42:706–711

    Article  CAS  PubMed  Google Scholar 

  • Tappeiner C, Klotsche J, Schenck S et al (2015b) Temporal change in prevalence and complications of uveitis associated with juvenile idiopathic arthritis: data from a cross-sectional analysis of a prospective nationwide study. Clin Exp Rheumatol 33:936–944

    CAS  PubMed  Google Scholar 

  • Tappeiner C, Schenck S, Niewerth M et al (2016a) Impact of antiinflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a nationwide pediatric rheumatology database. Arthritis Care Res 68:46–54

    Article  CAS  Google Scholar 

  • Tappeiner C, Mesquida M, Adan A et al (2016b) Evidence for tocilizumab as a treatment option in refractory uveitis associated with juvenile idiopathic arthritis. J Rheumatol 43:2183–2188

    Article  CAS  PubMed  Google Scholar 

  • Tappeiner C, Klotsche J, Sengler C et al (2018) Risk factors and biomarkers for the occurrence of uveitis in juvenile idiopathic arthritis: data from the Inception Cohort of Newly diagnosed patients with juvenile idiopathic arthritis study. Arthritis Rheumatol 70:1685–1694

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Thorne JE, Woreta FA, Dunn JP et al (2010) Risk of cataract development among children with juvenile idiopathic arthritis-related uveitis treated with topical corticosteroids. Ophthalmology 117:1436–1441

    Article  PubMed  Google Scholar 

  • Tosi GM, Sota J, Vitale A et al (2019) Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis. Clin Exp Rheumatol 37:680–683

    PubMed  Google Scholar 

  • Tugal-Tutkun I, Havrlikova K, Power WJ, Foster CS (1996) Changing patterns in uveitis of childhood. Ophthalmology 103:375–383

    Article  CAS  PubMed  Google Scholar 

  • Tynjälä P, Lindahl P, Honkanen V et al (2007) Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis 66:548–550

    Article  CAS  PubMed  Google Scholar 

  • Vidqvist KL, Malin M, Varjolahti-Lehtinen T, Korpela MM (2013) Disease activity of idiopathic juvenile arthritis continues through adolescence despite the use of biologic therapies. Rheumatology 52:1999–2003

    Article  PubMed  Google Scholar 

  • Vitale AT, Graham E, de Boer JH (2013) Juvenile idiopathic arthritis-associated uveitis: clinical features and complications, risk factors for severe course, and visual outcome. Ocul Immunol Inflamm 21:478–485

    Article  PubMed  Google Scholar 

  • Walscheid K, Glandorf K, Rothaus K et al (2020) Enthesitis-related arthritis: prevalence and complications of associated uveitis in children and adolescents from a population-based nation-wide study in Germany. J Rheumatol, im Druck 48:262–269

    Google Scholar 

  • Walscheid K, Hennig M, Heinz C et al (2014) Correlation between disease severity and presence of ocular autoantigens in juvenile idiopathic arthritis-associated uveitis. Invest Ophthalmol Vis Sci 55:3447–3453

    Article  PubMed  Google Scholar 

  • Wildschütz L, Ackermann D, Witten A et al (2019) Transcriptomic and proteomic analysis of iris tissue and aqueous humor in juvenile idiopathic arthritis-associated uveitis. J Autoimmun 100:75–83

    Article  CAS  PubMed  Google Scholar 

  • Wolf MD, Lichter PR, Ragsdale CG (1987) Prognostic factors in the uveitis of juvenile rheumatoid arthritis. Ophthalmology 94:1242–1248

    Article  CAS  PubMed  Google Scholar 

  • Zannin ME, Buscain I, Vittadello F et al (2012) Timing of uveitis onset in oligoarticular juvenile idiopathic arthritis (JIA) as the main predictor of severe course uveitis. Acta Ophthalmol 90:91–95

    Article  CAS  PubMed  Google Scholar 

  • Zulian F, Balzarin M, Falcini F et al (2010) Abatacept for severe anti-tumour necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis. Arthritis Care Res 82:821–825

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Uveitis-Zentrum, Augenzentrum am St. Franziskus Hospital, Münster, Deutschland

    Arnd Heiligenhaus

  2. Augenklinik, Pallas Klinik, Olten, Schweiz

    Christoph Tappeiner

  3. Klinik für Augenheilkunde, Universitätsklinikum Duisburg-Essen, Essen, Deutschland

    Christoph Tappeiner

  4. Medizinische Fakultät, Universität Bern, Bern, Schweiz

    Christoph Tappeiner

  5. Klinik für Kinderheilkunde III, Bereich Kardiologie, Universitätsklinikum Essen, Essen, Deutschland

    Ulrich Neudorf

Authors
  1. Arnd Heiligenhaus
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Christoph Tappeiner
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ulrich Neudorf
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Arnd Heiligenhaus .

Editor information

Editors and Affiliations

  1. Klinik für Kinder- und Jugendmedizin, Universitätsklinikum Aachen, Aachen, Deutschland

    Norbert Wagner

  2. Sektion Rheumatologie der Klinik für Pädiatrie m.S. Pneumologie, Immunologie und Intensivmedizin mit Bereich Rheumatologie, im Sozialpädiatrischen ZentrumCharité - Universitätsmedizin Berlin, Berlin, Deutschland

    Günther Dannecker

  3. Sektion Rheumatologie der Klinik für Pädiatrie m.S. Pneumologie, Immunologie und Intensivmedizin mit Bereich Rheumatologie, im Sozialpädiatrischen ZentrumCharité - Universitätsmedizin Berlin, Berlin, Deutschland

    Tilmann Kallinich

Rights and permissions

Reprints and permissions

Copyright information

© 2022 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Heiligenhaus, A., Tappeiner, C., Neudorf, U. (2022). Uveitis bei Kindern und Jugendlichen mit juveniler idiopathischer Arthritis. In: Wagner, N., Dannecker, G., Kallinich, T. (eds) Pädiatrische Rheumatologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-60410-6_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-60410-6_31

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-60409-0

  • Online ISBN: 978-3-662-60410-6

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation